TickerWorth Open the interactive view →

RXO, Inc. (RXO) — Available-Data Snapshot

Updated Sep 3, 2026 · available-data snapshot · descriptive, not a DCF, not advice

Price
$19.79
Market cap
$3,263,888,128
52-week high
$29.90
52-week low
$10.43
Currency
USD
Exchange
NYSE

We don't publish a discounted-cash-flow fair value for RXO, Inc. (RXO) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.

On the numbers we do have, RXO trades at a recent price of $19.79, a market capitalisation of about $3,263,888,128, sitting 48% of the way up its 52-week range ($10.43–$29.90), on the NYSE.

The standard alternative to a DCF is relative valuation — comparing RXO's trading multiples against a sector benchmark. Here that gives Fwd P/E of 32.8× (richer than the peer median of 24.5×); P/B of 2.2× (cheaper than the peer median of 18.8×); P/S of 0.5× (cheaper than the peer median of 4.9×); EV/EBITDA of 43.2× (richer than the peer median of 20.2×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.

The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. RXO shows a price-to-book (P/B) of 2.17 and book value of $9.13 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.

Finally, a price-based read — explicitly not a valuation. RXO is in a mixed trend, trading -33.8% from its 52-week high. Over the past year the stock is +22.9%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.

What's missing and why: we can't build a DCF for RXO because the data source doesn't reliably provide dividend. We would rather say so plainly than manufacture a precise-looking number from nothing. As coverage improves, or for larger and more widely-followed listings, a full intrinsic-value model becomes possible.

Relative valuation — RXO vs peers

MultipleRXOPeer median
Fwd P/E32.8×24.5×richer than
P/B2.2×18.8×cheaper than
P/S0.5×4.9×cheaper than
EV/EBITDA43.2×20.2×richer than

Sector benchmark (bellwethers, not direct competitors).

Asset / book-value view

Price / book (P/B)
2.17
Book value / share
$9.13

Price-to-book compares the market price to the accounting net-asset value per share. Most useful for asset-heavy businesses, banks and insurers.

Price-based snapshot

50-day avg
$24.38
200-day avg
$18.78
From 52-wk high
-33.8%
1-year momentum
+22.9%

Price-based, not a valuation. Moving-average trend and 52-week position describe where the stock has traded — they say nothing about fair value.

Explore more

Most undervalued stocks (per our valuation) · All valued stocks · Interactive RXO view

A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is an educational tool, not a licensed investment adviser. Figures are estimates derived from public market data and can be wrong, stale or incomplete.